Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
53 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
−9 pts over 3 months50% of ENTX’s tracked signals bullish
FundamentalsNeutral
TechnicalsNeutral
Alternative dataNeutral
SentimentBullish
Price$2.77
Year Range$1 – $3.92
Market Cap$435M
IndustryBiotechnology

What Is Entera Bio’s AI Stock Analysis?

Entera Bio’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Entera Bio’s momentum in near-real time.

Entera Bio (ENTX) has an AltIndex AI Score of 53/100, currently a Hold signal. The AI Score distills Entera Bio's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Entera Bio’s Full AI Analysis

Entera Bio is a biotechnology company focused on the development and commercialization of orally delivered large molecule therapeutics. The company is leveraging its proprietary oral drug delivery platform to transform the way biologics are administered, with the goal of improving patient compliance and outcomes. Entera Bio's lead clinical programs are in the areas of osteoporosis and hypoparathyroidism, which represent significant unmet medical needs.

Fundamental Analysis

The fundamental analysis of Entera Bio reveals a mixed picture. Revenue for the last quarter was $0, which is consistent with the same quarter from the previous year and the quarter before it, reflecting stability and consistency but also a lack of revenue growth. This is an important consideration since it underscores that Entera Bio is still in the developmental stage, heavily relying on future product approvals and commercial success.

Premium

Keep reading AltIndex’s full AI analysis of Entera Bio — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving ENTX’s AI Score?

Fundamentals

Revenue for the last quarter was $0. This is equal to the revenue of the quarter before it, showing stability. Also, this is equal to the revenue of the same quarter last year, indicating consistency. Net income for the last quarter was $-7.3M. This represents a decrease of 108.62% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 175.30%, which may be a cause for concern. Ebitda for the last quarter was $-4.6M. This represents a decrease of 30.45% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 72.25%, which may be a cause for concern.

See Entera Bio’s earnings and insider transactions.

Technicals

Today's stock price is $2.77. This represents a decrease of 6.42% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 17.87%, suggesting a positive long-term trend. The trend is bullish. The current SMA10 is $2.59, which is higher than the previous SMA10 of $2.58. This indicates a potential upward trend in price movement. The RSI is 73, indicating a potentially overbought (bearish) condition.

See the full technical analysis and price prediction.

Alternative data

The business outlook among employees at Entera Bio is low (an estimate of only 0% of employees have a positive outlook), a concerning sign. Entera Bio has an estimate of 2,000 visitors to their webpage. The number of visitors is down by -33% in the last couple of months, a worrisome trend as this can indicate a loss in customers.

Explore Entera Bio’s job postings, web traffic and app downloads.

Sentiment & social

Entera Bio has 32 followers on their Instagram page. The number of followers is up by 3% in the last couple of months, indicating an increased interest in the company. Entera Bio has 84 followers on their Twitter page. The number of followers is up by 11% in the last couple of months, indicating an increased interest in the company.

Track Entera Bio’s market sentiment.

Frequently Asked Questions: Entera Bio AI Stock Analysis

Entera Bio's AltIndex AI Score is 53/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Entera Bio a Hold (53/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Entera Bio — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ENTX AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.